BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27595546)

  • 21. Profiling of cis- and trans-acting factors supporting noncanonical splice site activation.
    Erkelenz S; Poschmann G; Ptok J; Müller L; Schaal H
    RNA Biol; 2021 Jan; 18(1):118-130. PubMed ID: 32693676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Zhu J; Mayeda A; Krainer AR
    Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.
    Zahler AM; Damgaard CK; Kjems J; Caputi M
    J Biol Chem; 2004 Mar; 279(11):10077-84. PubMed ID: 14703516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition.
    Heiner M; Hui J; Schreiner S; Hung LH; Bindereif A
    RNA Biol; 2010; 7(1):56-64. PubMed ID: 19946215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperative-binding and splicing-repressive properties of hnRNP A1.
    Okunola HL; Krainer AR
    Mol Cell Biol; 2009 Oct; 29(20):5620-31. PubMed ID: 19667073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.
    Dery KJ; Gaur S; Gencheva M; Yen Y; Shively JE; Gaur RK
    J Biol Chem; 2011 May; 286(18):16039-51. PubMed ID: 21398516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3' splice site.
    Doktor TK; Schroeder LD; Vested A; Palmfeldt J; Andersen HS; Gregersen N; Andresen BS
    Hum Mutat; 2011 Feb; 32(2):220-30. PubMed ID: 21120954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exon-Specific U1s Correct SPINK5 Exon 11 Skipping Caused by a Synonymous Substitution that Affects a Bifunctional Splicing Regulatory Element.
    Dal Mas A; Fortugno P; Donadon I; Levati L; Castiglia D; Pagani F
    Hum Mutat; 2015 May; 36(5):504-12. PubMed ID: 25665175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations.
    Alfen F; Putscher E; Hecker M; Zettl UK; Hermann A; Lukas J
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skipping of an exon with a nonsense mutation in the DMD gene is induced by the conversion of a splicing enhancer to a splicing silencer.
    Zhu Y; Deng H; Chen X; Li H; Yang C; Li S; Pan X; Tian S; Feng S; Tan X; Matsuo M; Zhang Z
    Hum Genet; 2019 Jul; 138(7):771-785. PubMed ID: 31168774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel role of U1 snRNP: Splice site selection from a distance.
    Singh RN; Singh NN
    Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):634-642. PubMed ID: 31042550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All reported non-canonical splice site variants in GLA cause aberrant splicing.
    Okada E; Horinouchi T; Yamamura T; Aoto Y; Suzuki R; Ichikawa Y; Tanaka Y; Masuda C; Kitakado H; Kondo A; Sakakibara N; Ishiko S; Nagano C; Ishimori S; Usui J; Yamagata K; Matsuo M; Nozu K
    Clin Exp Nephrol; 2023 Sep; 27(9):737-746. PubMed ID: 37254000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput analysis revealed mutations' diverging effects on
    Souček P; Réblová K; Kramárek M; Radová L; Grymová T; Hujová P; Kováčová T; Lexa M; Grodecká L; Freiberger T
    RNA Biol; 2019 Oct; 16(10):1364-1376. PubMed ID: 31213135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complexities of 5'splice site definition: implications in clinical analyses.
    De Conti L; Skoko N; Buratti E; Baralle M
    RNA Biol; 2012 Jun; 9(6):911-23. PubMed ID: 22617876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease.
    Chang WH; Niu DM; Lu CY; Lin SY; Liu TC; Chang JG
    PLoS One; 2017; 12(4):e0175929. PubMed ID: 28430823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
    Tange TO; Damgaard CK; Guth S; Valcárcel J; Kjems J
    EMBO J; 2001 Oct; 20(20):5748-58. PubMed ID: 11598017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencer elements as possible inhibitors of pseudoexon splicing.
    Sironi M; Menozzi G; Riva L; Cagliani R; Comi GP; Bresolin N; Giorda R; Pozzoli U
    Nucleic Acids Res; 2004; 32(5):1783-91. PubMed ID: 15034146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.